Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Pain and CYP3A5[original query] |
|---|
| The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment. Clinical pharmacology and therapeutics 2005 Nov 78 (5): 551-8. Fiegenbaum Marilu, da Silveira Fabiano R, Van der Sand Cézar R, Van der Sand Luiz Carlos, Ferreira Maria E W, Pires Renan C, Hutz Mara |
| Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. Journal of analytical toxicology 2006 1 29 (7): 590-8. Jin Ming, Gock Susan B, Jannetto Paul J, Jentzen Jeffrey M, Wong Steven |
| A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state. Cancer chemotherapy and pharmacology 2009 Feb 63 (3): 477-89. O'Bryant C L, Lieu C H, Leong S, Boinpally R, Basche M, Gore L, Leonardi K, Schultz M K, Hariharan S, Chow L, Diab S, Gibbs A, Eckhardt S |
| Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery. European journal of anaesthesiology 2011 Apr 28 (4): 245-50. Zhang Wei, Yuan Jing-Jing, Kan Quan-Cheng, Zhang Li-Rong, Chang Yan-Zi, Wang Zhong-Yu, Li Zhi-So |
| Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity. Cancer chemotherapy and pharmacology 2011 Dec 68 (6): 1633-8. Guilhaumou Romain, Solas Caroline, Bourgarel-Rey Veronique, Quaranta Sylvie, Rome Angelique, Simon Nicolas, Lacarelle Bruno, Andre Nicol |
| Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients. International journal of clinical pharmacology and therapeutics 2013 May 51 (5): 383-92. Kim Kye-Min, Kim Ho-Sook, Lim Se Hun, Cheong Soon Ho, Choi Eun-Jung, Kang Hyun, Choi Hey-Ran, Jeon Jin-Woo, Yon Jun Heum, Oh Minkyung, Shin Jae-Go |
| Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenetics and genomics 2014 Apr 24 (4): 185-94. Barratt Daniel T, Bandak Benedikte, Klepstad Pål, Dale Ola, Kaasa Stein, Christrup Lona L, Tuke Jonathan, Somogyi Andrew |
| Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study. Clinical therapeutics 2015 Nov . Bosilkovska Marija, Ing Lorenzini Kuntheavy, Uppugunduri Chakradhara Rao S, Desmeules Jules, Daali Youssef, Escher Moni |
| Relationship between the plasma fentanyl and serum 4ß-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. Drug metabolism and pharmacokinetics 2016 Jun 31 (3): 242-8. Ishida Takuya, Naito Takafumi, Sato Hikaru, Kawakami Junic |
| Pharmacogenomics of analgesics in anesthesia practice: A current update of literature. Journal of anaesthesiology, clinical pharmacology 2018 8 34 (2): 155-160. Gray Keith, Adhikary Sanjib D, Janicki Pio |
| Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects. Basic & clinical pharmacology & toxicology 2018 Oct . Saiz-Rodríguez Miriam, Ochoa Dolores, Herrador Coral, Belmonte Carmen, Román Manuel, Alday Enrique, Koller Dora, Zubiaur Pablo, Mejía Gina, Hernández-Martínez María, Abad-Santos Francis |
| Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study. Pain practice : the official journal of World Institute of Pain 2019 7 19 (8): 836-847. Margarit César, Roca Reyes, Inda María-Del-Mar, Muriel Javier, Ballester Pura, Moreu Rocío, Conte Anna Lucia, Nuñez Angela, Morales Domingo, Peiró Ana |
| Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer. European review for medical and pharmacological sciences 2019 Nov 23 (21): 9393-9410. Pu J, Wang N, Huang Z-K, He X-Y, Yuan H |
| Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management. The journal of applied laboratory medicine 2019 05 3 (6): 954-964. Hosseinnejad Keivan, Yin Tyler, Gaskins Jeremy T, Stauble M Elaine, Wu Yanhong, Jannetto Paul, Langman Loralie L, Jortani Saeed |
| Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism. Frontiers in pharmacology 2021 5 12 660639. Mejía-Abril Gina, Zubiaur Pablo, Navares-Gómez Marcos, Villapalos-García Gonzalo, Román Manuel, Ochoa Dolores, Abad-Santos Francis |
| Dataset of the first report of pharmacogenomics profiling in an outpatient spine setting. Data in brief 2021 3 35 106832. Cottrill Ethan, Pennington Zach, Lai Chun Wan Jeffrey, Ehresman Jeff, Jiang Bowen, Ahmed A Karim, Zhu Alex, Perdomo-Pantoja Alexander, Sciubba Daniel M, Witham Timothy, Lee Chun Hin, MacDonald Kevin, Theodore Nichol |
| Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
| Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study. BMC pharmacology & toxicology 2023 11 24 (1): 64. Jing Yang, Ying-Zi Sun, Qun-Fang Li, Zheng Fu, Yu-Yao Guan, Chao Song, Lei Zhe |
| Impacts of genetic polymorphisms and cancer cachexia on naldemedine pharmacokinetics and bowel movements in patients receiving opioid analgesics. Fundamental & clinical pharmacology 2024 1 . Emi Nakatsugawa, Takafumi Naito, Kaito Shibata, Ryo Kitajima, Junichi Kawaka |
- Page last reviewed:Feb 1, 2024
- Content source: